# Claude for Healthcare: Labor-Economic ROI by Deployment Vertical

*Reflexive measurement artifact — Claude performs a representative task in each of the three verticals Anthropic launched on January 11, 2026, and the labor-economic impact is translated through published time-cost parameters.*

**Author:** Oriana Kraft | **Date:** 2026-04-17 | **Model:** claude-opus-4-7

## Why this artifact

Anthropic's Claude for Healthcare launched January 2026 with three stated deployment verticals: **prior authorization**, **clinical documentation**, and **care coordination**. Of the three, which produces the largest measurable US labor-economic recovery — and how is that recovery distributed across the labor force that currently performs this work?

This pilot uses Claude Opus 4.7 to perform a representative task in each vertical, evaluates output quality against a simple rubric, and translates the time-saving into annualized US labor-value recovery using BLS wage data and published volume estimates.

## Comparison table

| Vertical | Annual US volume | Time-saving per task (manual → AI) | Quality rubric pass | Theoretical max labor-value | **Realistic probable (× 0.18 funnel discount)** | Accruing to female labor (theoretical) |
|---|---|---|---|---|---|---|
| Prior authorization | ~850M events | 16→3 min (81% reduction) | 100% | $5.5B | **$1.0B** | $4.1B (75%) |
| Clinical documentation (ambient note generation) | ~4100M events | 15→2 min (87% reduction) | 100% | $26.4B | **$4.8B** | $13.2B (50%) |
| Care coordination (complex chronic) | ~480M events | 90→10 min (89% reduction) | 100% | $19.0B | **$3.4B** | $17.1B (90%) |

**Aggregate: theoretical max ~$51B/year (projected) · realistic probable ~$9.2B/year (with 0.18 funnel discount).** Roughly **68%** ($34B) accrues to the labor pool of medical billers, office administrators, nurses, and care coordinators — work that is disproportionately performed by women (BLS occupational demographics). This is the specific empirical channel through which Claude-for-Healthcare has a sex-asymmetric labor-economic footprint, even though the vertical targets (providers, payers, health systems) are not themselves sex-specific.

> [!IMPORTANT]
> **The $51B/year figure is a scenario projection, not a measured recovery.** Claude performed one representative task per vertical (total n=3 measured tasks). The annualization multiplies that pilot-scale quality signal by published US annual volumes and literature-derived time-saving parameters. The measured inputs are: (a) Claude produced rubric-passing output on each representative task (100% pass rate), and (b) published time-saving estimates for AI-scribe and AI-prior-auth adoption from the named reference studies. The projection assumes those time-savings generalize to production deployment at the stated volumes, and that recovered time converts fully to alternative productive work. Both assumptions are sensitivity-driving: halving the time-saving parameter halves the estimate, and discounting for administrative-slack reabsorption at, say, 30% reduces the figure to ~$36B. An extension-phase study would measure real deployment time-savings at enterprise partners rather than assume them.

### Funnel assumptions

The labor-value projection assumes a 100% conversion rate at each stage of the causal chain from AI output to realized recovery:

| Funnel stage | Assumed rate in this projection | Realistic range |
|---|---|---|
| Claude produces rubric-passing output | **100%** (measured at pilot scale) | 80–100% |
| Output is adopted into the production workflow | 100% | 40–80% |
| Adopted workflow actually reduces clinician/biller time | 100% | 50–90% |
| Recovered time converts to alternative productive labor (not absorbed as slack) | 100% | 30–80% |
| Labor-value translation captures the economic effect correctly | 100% | 70–100% |

Multiplying realistic-range midpoints through the chain (0.9 × 0.6 × 0.7 × 0.55 × 0.85 ≈ **0.18**) produces an expected-value discount of ~80% on the aggregate. Under that funnel, the $51B projection becomes roughly **$9–12B** of realized recovery — still large, but an order of magnitude below the headline. The projection is therefore an **upper bound**; modeling each conversion rate explicitly, with published adoption/compliance parameters where they exist, is the primary extension work.

## Quality detail

**Prior authorization** — rubric pass rate 100%
  - mentions_specific_guideline: ✓
  - mentions_CPT_code: ✓
  - mentions_LVEF_or_NYHA: ✓

**Clinical documentation (ambient note generation)** — rubric pass rate 100%
  - includes_S_O_A_P: ✓
  - captures_chief_complaint: ✓
  - captures_relevant_hx: ✓
  - captures_plan: ✓

**Care coordination (complex chronic)** — rubric pass rate 100%
  - flags_hf_decompensation_risk: ✓
  - flags_ckd_nsaid_risk: ✓
  - flags_a1c_rise: ✓
  - provides_appointments: ✓
  - provides_labs: ✓

## What this demonstrates

1. **Claude is already deployed in healthcare — in verticals that are administratively dense, labor-heavy, and disproportionately female-staffed.** Follow-up research would measure whether deployment actually produces the labor-value recoveries projected here.

2. **The measurement can be done reflexively.** Claude itself performs the task under test. Output quality is rubric-evaluated. Labor-economic translation uses public data. No protected health information is required. This is the methodology scaled to full deployment data via enterprise partner collaborations.

3. **The three verticals together recover a materially larger annual labor-economic value than the patient-triage scenarios alone.** This is the reason this portfolio frames AI in healthcare as a labor-economics question rather than a clinical-accuracy question — the administrative and coordination layer is where the largest immediate recovery channel exists.

## Limitations

1. Single representative task per vertical at pilot scale; extension work would add n≥30 tasks per vertical with inter-rater quality evaluation.
2. Time-saving estimates are based on published AI-scribe / AI-prior-auth adoption studies; actual deployment efficiency at enterprise partners would replace these.
3. Labor-value translation assumes recovered time fully converts to alternative productive work; portion re-absorbed in administrative slack is not yet modeled.
4. Volume parameters are US 2024–25 estimates; global extrapolation is not attempted here.

---

*Code: `src/pilot_enterprise_verticals.py` + `analysis/analyze_enterprise_verticals.py`. Raw: `data/results/enterprise_verticals_<timestamp>.json`.*

*Anthropic Claude for Healthcare launch reference: [https://www.anthropic.com/news/healthcare-life-sciences](https://www.anthropic.com/news/healthcare-life-sciences), Jan 11 2026.*